Endoscopic resection for non-ampullary duodenal subepithelial lesions: a retrospective cohort study
- PMID: 39085622
- PMCID: PMC11291567
- DOI: 10.1007/s00384-024-04698-5
Endoscopic resection for non-ampullary duodenal subepithelial lesions: a retrospective cohort study
Abstract
Purpose: This study aimed to assess the safety and efficacy of endoscopic submucosal dissection (ESD) and pre-cutting endoscopic mucosal resection (pEMR) in treating non-ampullary duodenal subepithelial lesions (NADSELs) and to evaluate the clinical utility of endoscopic ultrasound (EUS) before endoscopic resection (ER).
Methods: In this retrospective single-centre cohort study, we compared the clinical outcomes of patients with NADSELs who underwent ESD or pEMR between January 2014 and June 2023. The accuracies of EUS in determining the pathological type and origin of the lesions were evaluated using postoperative histopathology as the gold standard.
Results: Overall, 56 patients with NADSELs underwent ER in this study, including 16 and 40 treated with pEMR and ESD, respectively. There were no significant differences between the two groups in terms of en bloc resection rate, complete (R0) resection rate, perioperative complication rate, and postoperative hospital length of stay (P > 0.05). However, the pEMR group had significantly shorter median operational (13.0 min vs. 30.5 min, P < 0.001) and mean fasting (1.9 days vs. 2.8 days, P = 0.006) time and lower median hospital costs (¥12,388 vs. ¥19,579, P = 0.002). The accuracies of EUS in determining the pathological type and origin of the lesions were 76.8% and 94.6%, respectively, compared with histopathological evaluation.
Conclusions: EUS can accurately predict the origin of NADSELs. Suitable lesions determined to originate from the submucosa or more superficial layers using EUS can be treated using pEMR as it shortens the operational and recovery time, reduces hospitalisation costs, and achieves an R0 resection rate similar to ESD.
Keywords: Duodenum; Endoscopic submucosal dissection; Endoscopic ultrasound; Pre-cutting endoscopic mucosal resection; Subepithelial lesions.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Feasibility of endoscopic submucosal dissection for upper gastrointestinal submucosal tumors treatment and value of endoscopic ultrasonography in pre-operation assess and post-operation follow-up: a prospective study of 224 cases in a single medical center.Surg Endosc. 2016 Oct;30(10):4206-13. doi: 10.1007/s00464-015-4729-1. Epub 2016 Jan 28. Surg Endosc. 2016. PMID: 26823060
-
Endoscopic resection for duodenal subepithelial tumors: a single-center experience.Surg Endosc. 2017 Apr;31(4):1936-1946. doi: 10.1007/s00464-016-5200-7. Epub 2016 Aug 23. Surg Endosc. 2017. PMID: 27553800
-
Endoscopic ultrasound evaluation in the surgical treatment of duodenal and peri-ampullary adenomas.World J Gastroenterol. 2013 Jan 28;19(4):511-5. doi: 10.3748/wjg.v19.i4.511. World J Gastroenterol. 2013. PMID: 23382629 Free PMC article.
-
Approach to the endoscopic resection of duodenal lesions.World J Gastroenterol. 2016 Jan 14;22(2):600-17. doi: 10.3748/wjg.v22.i2.600. World J Gastroenterol. 2016. PMID: 26811610 Free PMC article. Review.
-
Underwater Endoscopic Mucosal Resection Versus Conventional Endoscopic Mucosal Resection for Superficial Non-ampullary Duodenal Epithelial Tumors ≤20 mm: A Systematic Review With Meta-analysis.J Clin Gastroenterol. 2023 Oct 1;57(9):928-936. doi: 10.1097/MCG.0000000000001763. J Clin Gastroenterol. 2023. PMID: 36084162
References
-
- Deprez PH, Moons L, OʼToole D et al (2022) Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 54(4):412–429 - PubMed
-
- Polkowski M (2005) Endoscopic ultrasound and endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of malignant submucosal tumors. Endoscopy 37(7):635–645. 10.1055/s-2005-861422 - PubMed
-
- Nishida T, Hirota S, Yanagisawa A et al (2008) Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. Int J Clin Oncol 13(5):416–430 - PubMed
-
- Panzuto F, Ramage J, Pritchard DM, van Velthuysen MF, Schrader J, Begum N, Sundin A, Falconi M, O’Toole D (2023) European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3. J Neuroendocrinol 35(8):e13306 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous